Reasons the Recent Rally May Not Last

Brittney Barrett |

Wall Street FinancialsYesterday was an unusual day for equities with the Commerce Department reporting flat U.S. growth for August across the economy. Every area from jobs to sales was stagnant in the month of August. When the economy is teetering on the edge of a recession, a lack of growth is rarely seen as worth celebrating, and yet the market rose.

There are several reasons for this, and they may be the same reasons that will prevent this from being an on-going volatility. In recent weeks, the market has been primarily defined by massive volatility. Many analysts had begun accepting the swings as the new standard in trading but then this week, the market has been edging higher more moderately, though no news seems to have been released that would have shocked it back into hesitant bullishness.

The explanation may be that shorts have begun shifting. As of this week, the NYSE short interest reached its highest level in roughly two years.

Volume on the market is low and many short are protecting their bets, driving up prices in spite of the lack of external impetus for a rise in prices.

In addition to the end of shorting, the current levels and forecasts appear to be driving contrarians. The contrarian view, adopted by many well known investors, is to act against the consensus forecast. Right now the mood on Wall Street is bearish. That pessimism is inspiring contrarian investors, presented with a platter of fallen stars still trading below 52-week highs, to invest.

Stocks, however, are not at their lowest levels of the past month so actual buying is slowing down and the deals slowly dissipate. Once the market evens and there are more finite indicators in terms of the direction of the market, the volatility swings may return.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
CAA21 CalAtlantic Group Inc 6.25% Sr Nt 2021 n/a n/a n/a 0


Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…